Nevro Corp (NYSE:NVRO)
$ 5.06 -0.26 (-4.89%) Market Cap: 188.65 Mil Enterprise Value: 166.94 Mil PE Ratio: 0 PB Ratio: 0.69 GF Score: 42/100

Nevro Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 07:40PM GMT
Release Date Price: $118.69 (-4.34%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

Okay, everybody. My name is Bob Hopkins. We're set to begin the next session. Thank you, everybody, for joining us here this afternoon. We're very excited to have the management team from Nevro here with us, including Keith Grossman, Andrew Galligan; and of course, Juliet Cunningham. So this will be a fireside chat format. I wanted to just thank the team from Nevro for being here. And if okay, we'll just dive right in with some questions.

Questions & Answers

Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

So Keith, yes, thank you for being here. I really appreciate it.

D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President

Thanks for having us, Bob.

Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research

You guys just reported your first quarter, but I did kind of want to ask a few follow-ups from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot